Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Asm Anisuzzaman"'
Publikováno v:
Cancer Research. 79:706-706
Purpose: Molecularly targeted agents will play a major role in the next generation of personalized cancer therapies. However, intrinsic and acquired resistance to targeted agents poses challenges to the success of such treatments. The Cancer Genome A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11d9d79dac7b5e7fd954e5164f7be67a
https://doi.org/10.1158/1538-7445.am2019-706
https://doi.org/10.1158/1538-7445.am2019-706
Publikováno v:
TAJ: Journal of Teachers Association. 24:6-10
The study was carried out to identify the compound responsible for hypolipidemic and hypoglycemic effects of Cajanus cajan (redgram). The methanol extract of redgram seeds was found to decrease fasting blood glucose and lipid profile (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::242c2341299806b79fb1efc8bbd39b77
https://doi.org/10.3329/taj.v24i1.37441
https://doi.org/10.3329/taj.v24i1.37441
Publikováno v:
Cancer Research. 78:680-680
Purpose: We have recently reported that FLLL12, a synthetic curcumin analog, induces apoptosis of lung cancer cells through a death receptor (DR) 5-dependent pathway and in squamous cell carcinoma of head and neck (SCCHN) by modifying multiple Bcl-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c15185076bf197fedb1518aa89404b5
https://doi.org/10.1158/1538-7445.am2018-680
https://doi.org/10.1158/1538-7445.am2018-680
Autor:
Park D; Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Anisuzzaman ASM; Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Magis AT; Institute for Systems Biology, Seattle, WA 98109, USA., Chen G; Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Xie M; Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Zhang G; Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Behera M; Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Sica GL; Department of Pathology and Laboratory Medicine, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Ramalingam SS; Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Owonikoko TK; Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA., Deng X; Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA.
Publikováno v:
Theranostics [Theranostics] 2021 Jul 25; Vol. 11 (17), pp. 8500-8516. Date of Electronic Publication: 2021 Jul 25 (Print Publication: 2021).
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2020 Sep; Vol. 19 (9), pp. 1955.
Autor:
Morishima S; Division of Pharmacology, Department of Biochemistry and Bioinformative Sciences, School of Medicine, University of Fukui, Eiheiji, Fukui 910-1193, Japan., Anisuzzaman ASM; Division of Pharmacology, Department of Biochemistry and Bioinformative Sciences, School of Medicine, University of Fukui, Eiheiji, Fukui 910-1193, Japan., Uwada J; Division of Pharmacology, Department of Biochemistry and Bioinformative Sciences, School of Medicine, University of Fukui, Eiheiji, Fukui 910-1193, Japan; Organization for Life Science Advancement Programs, Graduate School of Medicine, University of Fukui, Eiheiji, Fukui 910-1193, Japan., Yoshiki H; Division of Pharmacology, Department of Biochemistry and Bioinformative Sciences, School of Medicine, University of Fukui, Eiheiji, Fukui 910-1193, Japan., Muramatsu I; Division of Pharmacology, Department of Biochemistry and Bioinformative Sciences, School of Medicine, University of Fukui, Eiheiji, Fukui 910-1193, Japan; Organization for Life Science Advancement Programs, Graduate School of Medicine, University of Fukui, Eiheiji, Fukui 910-1193, Japan; Child Development Research Center, Graduate School of Medicine, University of Fukui, Eiheiji, Fukui 910-1193, Japan. Electronic address: muramatu@u-fukui.ac.jp.
Publikováno v:
Life sciences [Life Sci] 2013 Jul 19; Vol. 93 (1), pp. 17-23. Date of Electronic Publication: 2013 May 30.